Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Double-Crane In-Licenses Asia Rights to Oral COVID-19 Antiviral

Brii Bio Says mAb COVID Therapy Shows Promise for Later Stage Disease

Kintor Starts Global Phase III Trial of COVID-19 Therapy

Recbio and Rhegen Form JV to Develop mRNA Vaccines including COVID

Clover Reports COVID-19 Vaccine Meets Endpoints in Global Phase II/III Trial

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China